Cargando…
Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings
BACKGROUND/OBJECTIVE: Patients with ankylosing spondylitis (AS) experience symptoms and comorbidities that impact their health-related quality of life (HRQoL) and ability to work. This real-world, global survey was conducted among AS patients receiving tumor necrosis factor inhibitors (TNFis) to eva...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612885/ https://www.ncbi.nlm.nih.gov/pubmed/32826654 http://dx.doi.org/10.1097/RHU.0000000000001544 |
_version_ | 1784603532316377088 |
---|---|
author | Strand, Vibeke Deodhar, Atul Alten, Rieke Sullivan, Emma Blackburn, Stuart Tian, Haijun Gandhi, Kunal K. Jugl, Steffen M. Conaghan, Philip G. |
author_facet | Strand, Vibeke Deodhar, Atul Alten, Rieke Sullivan, Emma Blackburn, Stuart Tian, Haijun Gandhi, Kunal K. Jugl, Steffen M. Conaghan, Philip G. |
author_sort | Strand, Vibeke |
collection | PubMed |
description | BACKGROUND/OBJECTIVE: Patients with ankylosing spondylitis (AS) experience symptoms and comorbidities that impact their health-related quality of life (HRQoL) and ability to work. This real-world, global survey was conducted among AS patients receiving tumor necrosis factor inhibitors (TNFis) to evaluate both the frequency and severity of persistent symptoms, and the impact of pain and fatigue on HRQoL, employment status, and work activity. METHODS: Patients with AS and their treating physicians from 13 countries across 5 continents completed questionnaires capturing demographics, patient symptoms, current disease status, HRQoL, current therapy, employment status, and Work Productivity and Activity Impairment. RESULTS: Seven hundred five patients who had been receiving a TNFi for 3 months or more and completed both Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) pain and fatigue domains were included in the analysis; of these, 37.6% reported high BASDAI pain scores and 41.3% high BASDAI fatigue scores. Medical Outcomes Study–Short Form, 36-item version 2 domain, 5-dimensional EuroQoL Questionnaire, and 5-dimensional EuroQoL visual analog scale scores were significantly lower (p < 0.0001), and Work Productivity and Activity Impairment scores significantly higher (p < 0.0001), in patients with high levels of pain or fatigue than low levels. CONCLUSIONS: Globally, levels of pain and fatigue remained high in AS patients receiving TNFi treatment, which were significantly associated with reduced HRQoL and work productivity. Such persistent symptoms in usual care suggest a substantial unmet need in AS pharmacologic and nonpharmacologic therapeutic pathways. |
format | Online Article Text |
id | pubmed-8612885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-86128852021-11-29 Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings Strand, Vibeke Deodhar, Atul Alten, Rieke Sullivan, Emma Blackburn, Stuart Tian, Haijun Gandhi, Kunal K. Jugl, Steffen M. Conaghan, Philip G. J Clin Rheumatol Original Articles BACKGROUND/OBJECTIVE: Patients with ankylosing spondylitis (AS) experience symptoms and comorbidities that impact their health-related quality of life (HRQoL) and ability to work. This real-world, global survey was conducted among AS patients receiving tumor necrosis factor inhibitors (TNFis) to evaluate both the frequency and severity of persistent symptoms, and the impact of pain and fatigue on HRQoL, employment status, and work activity. METHODS: Patients with AS and their treating physicians from 13 countries across 5 continents completed questionnaires capturing demographics, patient symptoms, current disease status, HRQoL, current therapy, employment status, and Work Productivity and Activity Impairment. RESULTS: Seven hundred five patients who had been receiving a TNFi for 3 months or more and completed both Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) pain and fatigue domains were included in the analysis; of these, 37.6% reported high BASDAI pain scores and 41.3% high BASDAI fatigue scores. Medical Outcomes Study–Short Form, 36-item version 2 domain, 5-dimensional EuroQoL Questionnaire, and 5-dimensional EuroQoL visual analog scale scores were significantly lower (p < 0.0001), and Work Productivity and Activity Impairment scores significantly higher (p < 0.0001), in patients with high levels of pain or fatigue than low levels. CONCLUSIONS: Globally, levels of pain and fatigue remained high in AS patients receiving TNFi treatment, which were significantly associated with reduced HRQoL and work productivity. Such persistent symptoms in usual care suggest a substantial unmet need in AS pharmacologic and nonpharmacologic therapeutic pathways. Lippincott Williams & Wilkins 2021-12 2020-08-21 /pmc/articles/PMC8612885/ /pubmed/32826654 http://dx.doi.org/10.1097/RHU.0000000000001544 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Articles Strand, Vibeke Deodhar, Atul Alten, Rieke Sullivan, Emma Blackburn, Stuart Tian, Haijun Gandhi, Kunal K. Jugl, Steffen M. Conaghan, Philip G. Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings |
title | Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings |
title_full | Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings |
title_fullStr | Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings |
title_full_unstemmed | Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings |
title_short | Pain and Fatigue in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors: Multinational Real-World Findings |
title_sort | pain and fatigue in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: multinational real-world findings |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612885/ https://www.ncbi.nlm.nih.gov/pubmed/32826654 http://dx.doi.org/10.1097/RHU.0000000000001544 |
work_keys_str_mv | AT strandvibeke painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings AT deodharatul painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings AT altenrieke painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings AT sullivanemma painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings AT blackburnstuart painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings AT tianhaijun painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings AT gandhikunalk painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings AT juglsteffenm painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings AT conaghanphilipg painandfatigueinpatientswithankylosingspondylitistreatedwithtumornecrosisfactorinhibitorsmultinationalrealworldfindings |